This paper demonstrated a holographic fibre coupling method, which achieved a 98% reduction in the average search steps with an enhanced efficiency compared with the traditional method using FSM.

The update means Personalis and Tempus will now work to bring to market the NeXT Personal ® ultra-sensitive, tumor-informed minimal residual disease (MRD) test to detect cancer recurrence in four ...